All Articles

With $80B in AUM, Pzena launches its first active ETFs. Can its classic value approach stand out in the booming, competitive ETF marketplace?

Following positive safety data, Phanes Therapeutics expands trials for spevatamig, a first-in-class antibody targeting two cancer pathways at once.

From knitting injuries to problems with in-laws, medical codes are a costly mess. AI is now untangling the $36 billion problem, one bizarre diagnosis at a time.

Ress Life Investments reports a 1.7% NAV gain but sheds $84M in assets, pivoting to an earnout model. What does this mean for the life settlement market?

The Oklahoma drinkware giant integrates philanthropy into its DNA, pledging $1.8M for 2026 and showcasing a unique model for corporate giving.

With the hire of sales veteran Jamie Shreeves, Eagleview signals its intent to deepen its dominance in the rapidly modernizing P&C insurance technology market.

HCM giant Paylocity buys AI startup Grayscale, signaling a major push to automate high-volume hiring. But can it solve the efficiency puzzle without bias?

Lupin wins FDA approval for its generic dapagliflozin, a move set to slash costs for a blockbuster diabetes and heart drug and reshape patient care.

Brazil launches Fair Play, an AI prosecutor to identify online racism. It promises access to justice but faces scrutiny over ethics and accuracy.

A new survey reveals a paradox: while most Americans use online health tools, few trust them, highlighting the crucial role of human healthcare providers.

A new holding company from Rise8's founder offers an alternative to VC, aiming to scale mission-critical software without sacrificing founder autonomy.

US firm SunHydrogen opens a Japan office led by a top researcher, aiming to scale its solar hydrogen tech in one of the world's leading clean energy markets.

After three rejections, Outlook Therapeutics escalates its fight for US approval of a key wet AMD drug, already sold in Europe. Will the FDA bend?

AI firm Pixability adds creator economy authority Jamie Gutfreund to its board, signaling a major push to integrate data, ads, and creators for brands.

As AI drives DRAM costs to a breaking point, one startup's software uses AI to fight back, promising to slash server costs and expand memory capacity.

Following a viral two-hour sellout, Rachel Mansfield's cadootz! has secured over $3M to expand its ultra-clean kids' crackers into major retail.

A new national program provides free, virtual therapy to caregivers of people with ALS, tackling a silent crisis of burnout, grief, and isolation.

Miami startup Petwealth emerges from stealth with at-home PCR tests and key partnerships, aiming to revolutionize the $200B pet health industry.

The leading health system is deploying Midstream Health's AI agents to tackle operational costs and secure long-term financial sustainability.

Cybersecurity firm Minimus appoints elite tech lawyer Yael Nardi as CBO, signaling a radical new "operational powerhouse" strategy to dominate the market.